0001375151-19-000043.txt : 20190326 0001375151-19-000043.hdr.sgml : 20190326 20190326161218 ACCESSION NUMBER: 0001375151-19-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190322 FILED AS OF DATE: 20190326 DATE AS OF CHANGE: 20190326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FARR STEPHEN J CENTRAL INDEX KEY: 0001247666 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 19705438 MAIL ADDRESS: STREET 1: SFARR@ZOGENIX.COM CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_155363112291941.xml FORM 4 X0306 4 2019-03-22 0 0001375151 ZOGENIX, INC. ZGNX 0001247666 FARR STEPHEN J C/O ZOGENIX, INC. 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 1 1 0 0 President and CEO Stock Option (Right to Buy) 52.66 2019-03-22 4 A 0 160000 0 A 2029-03-22 Common Stock 160000.0 160000 D Restricted Stock Units 2019-03-22 4 A 0 20000 0 A Common Stock 20000.0 20000 D The option award shall vest in a series of forty-eight (48) successive, equal monthly installments beginning on April 15, 2019, subject to the reporting person's continued service to the Company on the applicable vesting dates. Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock. The restricted stock units vest in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date. Not applicable. /s/ Thomas Doyle, Attorney-in-fact for Stephen Farr 2019-03-26